Clinical Trial Update: Schizophrenia Sensory Gating Deficit With Quetiapine

View source ↗

Summary

A completed clinical trial evaluated the effect of quetiapine on sensory gating deficits in schizophrenia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• Quetiapine (quetiapine)

Snippet

Sponsor: New Mexico VA Healthcare System | Conditions: Schizophrenia | Status: COMPLETED